Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

Clinical trial NCT02289963 · COMPLETED

Trial details

NCT number

NCT02289963

Sponsor

Sanofi

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2015-01-01

Primary completion

2016-04-01

Enrollment

199

View on ClinicalTrials.gov